MyCardia
Pre-clinical- Indications
- Heart failure
Company intelligence / Profile preview
Avery Therapeutics
Tucson, Arizona, United Statesaverythera.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Avery Therapeutics is developing first-in-class immunomodulatory and tissue-engineered therapies, with its lead product—a tissue-engineered heart graft called MyCardia—currently in pre-clinical development for heart failure. The company’s approach aims to redirect the immune system to address diseases of aging, inflammation, and fibrosis. No clinical results have been reported as programs are pre-clinical.[4][5]
- Therapeutic areas
- OtherCardiovascularImmunology
- Modalities
- Tissue-engineered therapeuticsImmunomodulatory biologic therapeutics[1][2][3][4][5]
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
University of Arizona/Tech Launch Arizona (academic collaboration/inventors)[4]No major pharmaceutical or biotech partnerships publicly disclosed.
Beyond the preview
Go deeper on Avery Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avery Therapeutics.